Hatteras Venture Partners
Overview
Hatteras Venture Partners, founded in 2000, is a venture capital firm based in Durham, North Carolina . The firm focuses on investing in seed and early-stage opportunities in the life science, healthcare, and technology sectors, particularly in biopharmaceuticals, medical devices, diagnostics, and healthcare IT . They invest across the United States, with a focus on the Southeastern US .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CREATE Medicines | May 2026 | Series B | Lead |
| Incyclix Bio | Apr 2026 | Series B Extension | Co-investor |
| Endogenex | Mar 2026 | Series C Extension | Co-investor |
| Ten63 Therapeutics | Feb 2026 | Strategic | Co-investor |
| Ten63 Therapeutics | Feb 2026 | Strategic | Co-investor |
Key People
Christy L Shaffer
General Partner
Douglas Reed
General Partner
Michael Dial
General Partner
Robert Ingram
General Partner
Heather Madsen
Operating Partner
Fred Goldwater
Venture Partner
Holden Thorp
Venture Partner
Myla Lai-Goldman
Venture Partner
Robert Morff
Venture Partner
Ben Scruggs
Partner
Kenneth Lee
Partner
Lauren Pierce Flickinger
Partner
Parker Johnson
Head Of Investor Relations And Client Development
Kseniya Simpson
Principal
Graham Smith
Venture Capital Associate
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.